We recently updated our Privacy Notice and Terms of Use.
Med-IQ
Capacity Building in Hepatitis C: Choosing and Optimizing Treatment
Webcast Webcast

Capacity Building in Hepatitis C: Choosing and Optimizing Treatment


Presented by the AGA Institute and Med-IQ.

Duke MedicineMed-IQ

Time to Complete:
30 minutes
Released:
8/19/16
Expires:
8/18/17
PDF:

Maximum Credits:

0.5

Webcast Webcast
Time to Complete:
30 minutes

Released:
8/19/16

Expires:
8/18/17

PDF:

Maximum Credits:
0.5
Webcast Webcast

Time to Complete:
30 minutes
Released:
8/19/16
Expires:
8/18/17
PDF:


Maximum Credits:
0.5


Overview: In this Webcast, faculty discuss the most recent developments in the treatment of chronic hepatitis C virus (HCV), as well as their own frontline perspectives and barriers they encounter in practice. Data from clinical studies involving treatment-naïve and -experienced patients with HCV are also explored. Faculty also focus on the impact of cirrhosis on treatment decisions for patients with HCV.

CME Information:

Faculty
April G. Morris, NP
Liver Institute of Virginia
Richmond, VA

Gina Storrs, RN, CNP
Certified Adult Nurse Practitioner
Minnesota Gastroenterology PA             
St. Paul, MN

Paul Kwo, MD
Professor of Medicine
Medical Director of Liver Transplantation
Department of Medicine
Indiana University School of Medicine
Indianapolis, IN

Activity Planner
Julie Blum, PhD
Senior Clinical Content Manager
Med-IQ
Baltimore, MD

Maura H. Davis
Director of Education
American Gastroenterological Association
Bethesda, MD

Sandra Megally
Senior Manager, Education
American Gastroenterological Association
Bethesda, MD

Learning Objectives
After completing this educational activity, participants should be able to:

  • Discuss the benefits and limitations of novel direct-acting antiviral agents for the management of patients with chronic HCV infection
  • Evaluate the impact of prior treatment when choosing direct-acting antiviral therapy for HCV management

Target Audience
This activity is intended for nurse practitioners and physician assistants.

Series Overview/Statement of Need
The field of hepatitis C virus (HCV) is witnessing a virtual explosion of scientific advances related to disease identification and treatment. An unprecedented volume of data is continually being released, and the unmet need for patients with HCV has been so great in recent years that the Food and Drug Administration has extended priority status to several new therapies. This whirlwind evolution in treatment is beneficial only when clinicians are up-to-date and comfortable with the new options—a significant challenge for busy clinicians. Simultaneously, updated screening guidelines and substantial efforts to educate clinicians about those changes are leading to significant increases in the volume of patients with chronic HCV needing care. Recently published data illustrate that a large percentage of specialist physicians do not have the time, clinical capacity, or desire to treat these patients. As physicians in all areas of medicine face concurrent increasing patient volumes and time constraints, advanced practice nurses and physician assistants are increasingly being recognized as critical members of the care team. For the potential of scientific advances in HCV to be realized, it is crucial that these clinicians stay abreast of contemporary evidence and changes in guidelines.

Providership Statement
Presented by the AGA Institute and Med-IQ.

Accreditation/Designation Statements
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AGA Institute designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners: This activity is approved for 0.5 contact hour of continuing education by the American Association of Nurse Practitioners.  Program ID 16062214. This activity was planned in accordance with AANP CE Standards and Policies.

Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.5 hour(s) of Category I credit for completing this program.

Others: Other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Instructions to Receive Credit
To receive credit, read the introductory CME/CE material, watch the Webinar, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.

Original Release Date: August 19, 2016
Expiration Date: August 18, 2017
Estimated Time to Complete This Activity: 30 minutes

The evaluation, attestation, and post-test may be accessed by clicking the “Get Credit” tab at the bottom of the Webcast activity.

Disclosure Policy
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 

April G. Morris, NP
Consulting fees/advisory boards: AbbVie Inc., Bristol-Myers Squibb, Gilead Sciences, Inc., Merck & Co., Inc.

Gina Storrs, RN, CNP
Consulting fees/advisory boards: AbbVie Inc., Gilead Sciences, Inc., Merck & Co., Inc.

Paul Kwo, MD
Consulting fees/advisory boards: Abbott Laboratories, AbbVie Inc., Alnylam Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc.
Fees received for promotional/non-CME activities: Innovia
Contracted research: AbbVie Inc., Bristol-Myers Squibb, Conatus Pharmaceuticals Inc., Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc.

The peer reviewers and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or e-mail info@med-iq.com.

For more information about other Indiana University programs, please visit: http://cme.medicine.iu.edu.

Hardware/Software Requirements
Operating System
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer

Browser
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Download: http://www.mozilla.org/en-US/firefox/new/

Google Chrome - latest version
Download: http://www.google.com/chrome

Apple Safari - latest version
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/ 

For technical support, go to https://www.med-iq.com/support-manual.html.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.

Acknowledgment of Commercial Support
This activity is supported by educational grants from AbbVie and Gilead Sciences, Inc.

Copyright
© 2016 the AGA Institute and Med-IQ®. All rights reserved.


Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.